SVA Guidelines/ Directive/ Circular Related to Registered Products

NPRA Banner

Guidelines/ Directive/ Circular Related to Registered Products

Guidelines
Directive
Circular

APPENDIX 34 - GUIDELINE FOR PRODUCT QUALITY REPORTING AND RECALL PROCEDURES GUIDELINE ON CONTROL OF NITROSAMINE IMPURITIES IN PHARMACEUTICAL PRODUCTS GUIDELINE ON REPORTING OF MEDICINE SHORTAGE AND DISCONTINUATION IN MALAYSIA

Direktif Berkenaan Pelaksanaan Pelaporan Gangguan dan Pemberhentian Bekalan Ubat-Ubatan Di Malaysia Berdasarkan Guideline on Reporting of Medicine Shortage and Discontinuation In Malaysia Direktif Berkenaan Keperluan Pengujian Kandungan Diethylene Glycol (DEG) dan Ethylene Glycol (EG) ke atas Bahan Aktif / Excipient dan / atau Produk Siap dalam Bentuk Dos Cecair untuk Kegunaan Dalaman (Oral) yang Mengandungi Bahan Aktif / Excipient Berisiko

PEKELILING BERKENAAN KAWALAN IMPURITI NITROSAMINES DALAM PRODUK FARMASEUTIKAL PEKELILING BERKENAAN KEPERLUAN PENGUJIAN IMPURITI NITROSAMINE BAGI PRODUK YANG MENGANDUNGI ANGIOTENSIN II RECEPTOR BLOCKERS (ARB), RANITIDINE DAN METFORMIN

National Pharmaceutical Regulatory Agency (NPRA)

Lot 36, Jalan Universiti (Jalan Prof Diraja Ungku Aziz), 46200 Petaling Jaya, Selangor, Malaysia.

Phone: +603-7883 5400

DISCLAIMER

The Government of Malaysia and the National Pharmaceutical Regulatory Agency are not responsible for any loss or damage caused by the usage of any information obtained from this website.

Site Last Modified

Last Modified: Wednesday 05 August 2026, 11:52:08.

Online Services

QUEST3+ System

NPRA Support System

Online Public Engagement

Online Procurement Announcement

Guidelines/ Directive/ Circular Related to Registered Products

More Links

More Links

DISCLAIMER

Site Last Modified

Online Services

Search

Main Menu English

Choose Your Language